New Risk • Feb 23
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 36% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£448k free cash flow). Share price has been highly volatile over the past 3 months (31% average weekly change). Negative equity (-UK£4.0m). Shareholders have been substantially diluted in the past year (36% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (UK£359.9k market cap, or US$486.1k). Announcement • Dec 09
Iconic Labs Plc, Annual General Meeting, Dec 31, 2025 Iconic Labs Plc, Annual General Meeting, Dec 31, 2025. Location: the offices of amba company secretarial, services ltd, c o regus, 4th floor, one kingdom street, paddington central, london w2 6bd United Kingdom New Risk • Oct 21
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (20% average weekly change). Negative equity (-UK£3.7m). Revenue is less than US$1m. Market cap is less than US$10m (UK£381.8k market cap, or US$512.0k). Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Shareholders have been diluted in the past year (24% increase in shares outstanding). 